Baillie Gifford & Co’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,403
| Closed | -$3.2M | – | 273 |
|
|
2024
Q3 | $3.2M | Sell |
21,403
-49,668
| -70% | -$7.42M | ﹤0.01% | 237 |
|
|
2024
Q2 | $9.69M | Sell |
71,071
-10,135
| -12% | -$1.38M | 0.01% | 216 |
|
|
2024
Q1 | $12.3M | Sell |
81,206
-464
| -0.6% | -$70.1K | 0.01% | 217 |
|
|
2023
Q4 | $10.3M | Sell |
81,670
-4,651
| -5% | -$586K | 0.01% | 222 |
|
|
2023
Q3 | $8.08M | Sell |
86,321
-4,181
| -5% | -$392K | 0.01% | 222 |
|
|
2023
Q2 | $8.08M | Sell |
90,502
-1,191
| -1% | -$106K | 0.01% | 226 |
|
|
2023
Q1 | $9.83M | Buy |
91,693
+11
| +0% | +$1.18K | 0.01% | 222 |
|
|
2022
Q4 | $11.2M | Buy |
91,682
+3,185
| +4% | +$389K | 0.01% | 212 |
|
|
2022
Q3 | $9.14M | Buy |
88,497
+2,697
| +3% | +$279K | 0.01% | 218 |
|
|
2022
Q2 | $7.98M | Sell |
85,800
-8,851
| -9% | -$823K | 0.01% | 220 |
|
|
2022
Q1 | $11.1M | Buy |
94,651
+8,579
| +10% | +$1.01M | 0.01% | 232 |
|
|
2021
Q4 | $11.6M | Buy |
86,072
+2,638
| +3% | +$355K | 0.01% | 242 |
|
|
2021
Q3 | $13.3M | Buy |
83,434
+8,882
| +12% | +$1.42M | 0.01% | 237 |
|
|
2021
Q2 | $9.81M | Sell |
74,552
-27,742
| -27% | -$3.65M | ﹤0.01% | 247 |
|
|
2021
Q1 | $13.2M | Buy |
102,294
+55,139
| +117% | +$7.11M | 0.01% | 234 |
|
|
2020
Q4 | $7.87M | Buy |
+47,155
| New | +$7.87M | ﹤0.01% | 227 |
|